Christopher L. Lotz - Net Worth and Insider Trading
Christopher L. Lotz Net Worth
The estimated net worth of Christopher L. Lotz is at least $107 dollars as of 2024-12-28. Christopher L. Lotz is the Vice President of Finance, CFO of Qualigen Therapeutics Inc and owns about 25 shares of Qualigen Therapeutics Inc (QLGN) stock worth over $107. Details can be seen in Christopher L. Lotz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher L. Lotz has not made any transactions after 2021-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher L. Lotz
Christopher L. Lotz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher L. Lotz owns 2 companies in total, including Ritter Pharmaceuticals Inc (RTTR) , and Qualigen Therapeutics Inc (QLGN) .
Click here to see the complete history of Christopher L. Lotz’s form 4 insider trades.
Insider Ownership Summary of Christopher L. Lotz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RTTR | Ritter Pharmaceuticals Inc | 2020-06-06 | Vice President of Finance & CFO |
| QLGN | Qualigen Therapeutics Inc | 2021-04-16 | Vice President of Finance & CFO |
Christopher L. Lotz Latest Holdings Summary
Christopher L. Lotz currently owns a total of 1 stock. Christopher L. Lotz owns 25 shares of Qualigen Therapeutics Inc (QLGN) as of April 16, 2021, with a value of $107.
Latest Holdings of Christopher L. Lotz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics Inc | 2021-04-16 | 25 | 4.27 | 107 |
Holding Weightings of Christopher L. Lotz
Christopher L. Lotz Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher L. Lotz has made a total of 1 transactions in Qualigen Therapeutics Inc (QLGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Qualigen Therapeutics Inc is the acquisition of 5 shares on April 16, 2021, which cost Christopher L. Lotz around $5,022.
Insider Trading History of Christopher L. Lotz
- 1
Christopher L. Lotz Trading Performance
GuruFocus tracks the stock performance after each of Christopher L. Lotz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher L. Lotz is -6.59%. GuruFocus also compares Christopher L. Lotz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher L. Lotz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher L. Lotz's insider trading performs compared to the benchmark.
Performance of Christopher L. Lotz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.64 | | | | | |
| Relative Return to S&P 500(%) | -12.36 | | | | | |
Christopher L. Lotz Ownership Network
Christopher L. Lotz Owned Company Details
What does Ritter Pharmaceuticals Inc do?
Who are the key executives at Ritter Pharmaceuticals Inc?
Christopher L. Lotz is the Vice President of Finance & CFO of Ritter Pharmaceuticals Inc. Other key executives at Ritter Pharmaceuticals Inc include 10 percent owner Sekisui Diagnostics, Llc , director & Chairman & President & CEO Michael S. Poirier , and Vice President of Operations Shishir K. Sinha .
Ritter Pharmaceuticals Inc (RTTR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ritter Pharmaceuticals Inc Insider Transactions
Christopher L. Lotz Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher L. Lotz. You might contact Christopher L. Lotz via mailing address: 2042 Corte Del Nogal, Suite B, Carlsbad Ca 90211.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
